Ernexa Therapeutics Inc. Common Stock Share Price
NASDAQ: ERNAHealthcare
Live Ernexa Therapeutics Inc. Common Stock Share Price Chart
O H L
Ernexa Therapeutics Inc. Common Stock Performance Overview
Days Range
▼
$3.83Low
$3.94High
Markets Today
| Previous Close | $3.76 |
|---|---|
| Open | $3.85 |
| Volume | 33,101 |
| Day's Range | $3.83 - $3.94 |
| 52W Range | $3.18 - $71.50 |
| Market Cap | $4.56 M |
Historical Performance
| 1M Returns | -11.53 |
|---|---|
| 3M Returns | -39.35 |
| 6M Returns | -48.84 |
| 1Y Returns | -88.16 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Ernexa Therapeutics Inc. Common Stock Fundamentals
| Market Cap | $4.56 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -6.88 |
| EPS TTM | $-18.69 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.43 |
| EBITDA | $-9.06 M |
| Profit Margin | N/A |
| Market Cap | $4.56 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -6.88 |
| EPS TTM | $-18.69 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.43 |
| EBITDA | $-9.06 M |
| Profit Margin | N/A |
Ernexa Therapeutics Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$2.73 M | -$2.50 M | -$1.99 M | -$2.09 M | -$5.59 M | -$4.10 M |
| EBITDA | -$2.71 M | -$2.48 M | -$1.98 M | -$1.88 M | -$3.54 M | -$4.09 M |
| Interest Expense | $0 | $0 | $0 | -$27.00 K | $0 | $55.00 K |
| Depreciation | $18.00 K | $17.00 K | $17.00 K | $211.00 K | $2.05 M | $9.00 K |
| Income Before Tax | -$8.19 M | -$3.14 M | -$1.23 M | -$1.56 M | -$5.55 M | -$4.01 M |
| Income Tax Expense | $8.00 K | $3.00 K | $6.00 K | -$62.00 K | -$40.00 K | $0 |
| Net Income + | -$8.20 M | -$3.14 M | -$1.24 M | -$1.50 M | -$5.51 M | -$4.01 M |
| Net Profit Margin | - | - | - | - | - | - |
Ernexa Therapeutics Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $262.00 K | $37.00 K | $39.00 K | $2.00 K | $6.00 K | $6.00 K |
| Reserve & Surplus | -$239.74 M | -$242.88 M | -$244.13 M | -$245.64 M | -$251.14 M | -$255.16 M |
| Non-Current Liabilities | $571.00 K | $489.00 K | $458.00 K | $320.00 K | $227.00 K | $183.00 K |
| Current Liabilities | $10.44 M | $2.65 M | $2.14 M | $3.11 M | $3.46 M | $2.93 M |
| Total Liabilities | $11.01 M | $3.14 M | $2.60 M | $3.43 M | $3.68 M | $3.12 M |
| Fixed Assets | $67.00 K | $50.00 K | $92.00 K | $94.00 K | $88.00 K | $82.00 K |
| Current Assets | $2.21 M | $4.79 M | $3.38 M | $3.13 M | $10.00 M | $5.89 M |
| Total Assets | $5.06 M | $7.58 M | $6.17 M | $5.83 M | $10.54 M | $6.32 M |
Ernexa Therapeutics Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$8.20 M | -$3.14 M | -$1.24 M | -$1.50 M | -$5.51 M | -$4.01 M |
| Operating Cash Flow | -$2.06 M | -$2.53 M | -$1.27 M | -$1.15 M | -$2.26 M | -$4.15 M |
| Investing Cash Flow | $0 | $0 | -$22.00 K | -$15.00 K | -$2.00 K | -$3.00 K |
| Financing Cash Flow | $2.25 M | $4.93 M | $26.00 K | $0 | $9.56 M | $6.00 K |
| Change in Cash | $189.00 K | $2.40 M | -$1.27 M | -$1.16 M | $7.29 M | -$4.15 M |
Ernexa Therapeutics Inc. Common Stock Return Calculator
The Ernexa Therapeutics Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Ernexa Therapeutics Inc. Common Stock
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.
Popular Stocks
FAQs
What is the share price of Ernexa Therapeutics Inc. Common Stock today?
Ernexa Therapeutics Inc. Common Stock (ERNA) share price as of September 18, 2026 is $3.71. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Ernexa Therapeutics Inc. Common Stock?
Yes, Indian Investors can invest in the Ernexa Therapeutics Inc. Common Stock (ERNA) Share by opening an international trading account with Angel One.
How can I purchase Ernexa Therapeutics Inc. Common Stock shares in India?
Purchasing Ernexa Therapeutics Inc. Common Stock (ERNA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ernexa Therapeutics Inc. Common Stock (ERNA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Ernexa Therapeutics Inc. Common Stock?
Yes, you can purchase fractional shares of Ernexa Therapeutics Inc. Common Stock (ERNA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Ernexa Therapeutics Inc. Common Stock?
The market capitalization of Ernexa Therapeutics Inc. Common Stock on September 18, 2026, is $4.56 M.
In which sector Ernexa Therapeutics Inc. Common Stock belongs?
Ernexa Therapeutics Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Ernexa Therapeutics Inc. Common Stock stocks?
In order to invest in Ernexa Therapeutics Inc. Common Stock (ERNA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
